Robert D. Hardie - 06 Jul 2021 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Reporting relationship: 10%+ Owner
Issuer ticker: ABOS
Reported as of: 06 Jul 2021
Net transaction value: +$5,000,000
SEC form: 4
Accepted by SEC: 08 Jul 2021, 18:15:57 UTC
Prior SEC filing: 30 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Katherine Denby, Attorney-in-Fact

Key filing fact

Robert D. Hardie filed Form 4 for Acumen Pharmaceuticals, Inc. (ABOS) on 08 Jul 2021.

Key facts

This page summarizes Robert D. Hardie's Form 4 filing for Acumen Pharmaceuticals, Inc. (ABOS).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 08 Jul 2021, 18:15.

Change

Previous filing in this sequence was filed on 30 Jun 2021.
Current net transaction value: +$5,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABOS transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +2,950,484
Change %: +3289%
Price
Shares after: 3,040,193
Date: 06 Jul 2021
Ownership: See footnote
Footnotes: F1, F2

ABOS transaction

Common Stock

Purchase

Transaction value: $5,000,000
Shares: +312,500
Change %: +10%
Price: $16.00
Shares after: 3,352,693
Date: 06 Jul 2021
Ownership: See footnote
Footnotes: F2

ABOS transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +657,985
Change %
Price
Shares after: 657,985
Date: 06 Jul 2021
Ownership: See footnote
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABOS transaction Derivative

Series A-1 Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -1,634,515
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 1,634,515
Exercise price
Footnotes: F1, F2

ABOS transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -1,315,969
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 1,315,969
Exercise price
Footnotes: F1, F2

ABOS transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -657,985
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 657,985
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert D. Hardie is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.

Footnote F2

The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.

Footnote F3

The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.